Outset Medical (OM) Share-based Compensation Growth (3y) (2022 - 2026)
Outset Medical (OM) Share-based Compensation Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 5.29% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | 13.40% |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 0.56% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | - |
| 10 | Outset Medical | 78,728.30 | -286.57 Mn | 12.10 Mn | -26.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.05% |
| Dec 31, 2025 | -17.94% |
| Sep 30, 2025 | -11.90% |
| Jun 30, 2025 | -22.17% |
| Mar 31, 2025 | -15.91% |
| Dec 31, 2024 | -24.49% |
| Sep 30, 2024 | 30.66% |
| Jun 30, 2024 | 35.62% |
| Mar 31, 2024 | 11.92% |
| Dec 31, 2023 | -10.26% |
| Sep 30, 2023 | -7.82% |
| Jun 30, 2023 | 145.49% |
| Mar 31, 2023 | 145.08% |
| Dec 31, 2022 | 209.92% |
| Sep 30, 2022 | 215.76% |